🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 2a, open-label, multi-center study evaluating biomarkers and biodistr...
Status
Recruiting
Location
Academic Urology and Urogynecology of Arizona
Start Date
2025-10-30
Trial ID
NCT07332000
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of CAN-2409 immu...
Status
Active Not Recruiting
Location
Foothills Urology
Start Date
2016-05
Trial ID
NCT02768363
Treatments Being Tested
This is a phase I dose escalation study of CAN-2409 plus prodrug in patient...
Status
Completed
Location
University of Pennsylvania
Start Date
2017-05-04
Trial ID
NCT03131037
Treatments Being Tested
This phase III trial compares the effect of the combination of aglatimagene...
Status
Recruiting
Location
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
Start Date
2026-06-15
Trial ID
NCT07660094
Treatments Being Tested
The purpose of this clinical trial is to evaluate the effects of adding CAN...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital
Start Date
2020-10-13
Trial ID
NCT04495153
Treatments Being Tested
The purpose of this study is to characterize the safety, preliminary effica...
Status
Unknown
Location
Lee Health/Regional Cancer Center
Start Date
2015-10
Trial ID
NCT02446093
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of ProstAtak® im...
Status
Active Not Recruiting
Location
Arizona Center for Cancer Care - Gilbert
Start Date
2011-09
Trial ID
NCT01436968
Treatments Being Tested
The purpose of this study was to evaluate the safety and potential efficacy...
Status
Completed
Location
City of Hope Medical Center
Start Date
2007-03
Trial ID
NCT00589875
Treatments Being Tested